Finn RS, Crown J, Lang I, et al. Overall survival results from the randomized phase II study of palbociclib (P) in combination with letrozole (L) vs letrozole alone for frontline treatment of ER+/HER2– advanced breast cancer (PALOMA-1; TRIO-18). J Clin Oncol. 35, 2017 (suppl; abstr 1001).
Europese consensusaanbevelingen voor oligo-gemetastaseerd slokdarm-/maagcarcinoom
feb 2024 | Maag-darm-leveroncologie